Skip to main navigation Skip to search Skip to main content

Transcriptome-driven health status transversal-predictor analysis for health, food, microbiome, and disease markers for understanding lifestyle diseases

  • Tilman Todt
  • , Inge Van Bussel
  • , Lydia Afmann
  • , Lorraine Brennan
  • , Diana G. Ivanova
  • , Yoana Kiselova-Kaneva
  • , E. Louise Thomas
  • , Ralph Rüuhl*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

We developed a novel artificial intelligence (AI) approach based on machine learning to predict general health and food-intake parameters. This approach, named Transcriptome-driven Health status Transversal-predictor Analysis (THTA) is relevant for markers of diabesity and is based on a nontranscriptomic, mathematics-driven approach. The prediction was based on values derived from food consumption, dietary lipids and their bioactive metabolites, peripheral blood mononuclear cell (PBMC) mRNAbased transcriptome signatures, magnetic resonance imaging (MRI), energy metabolism measurements, microbiome analyses, and baseline clinical parameters, as determined in a cohort of 72 subjects. Our novel machine learning approach incorporated transcriptome data from PBMCs as a “one-method” approach to predict 77 general health status markers for the broad stratification of the diabesity phenotype. These markers would usually necessitate measurements using 16 different methods. The PBMC transcriptome was used to determine these 77 basic and background health markers with very high accuracy in a transversalpredictor establishment group (Pearson’s correlations r = 0.98 ranging from 0.94 to 0.99). These collected variables provide valuable insides into which individual factor(s) are mainly target diabesity. Based on the “establishment group” prediction approach, a further “confirmation group” prediction approach was performed, achieving a predictive potential r = 0.59 (ranging from 0.19 to 0.98) for these 77 variables. This “one-method” approach enables the simultaneous monitoring of a large number of healthstatus variables relevant to diabesity and may facilitate the monitoring of therapeutic and preventive strategies. In summary, this novel technique, which is based on PBMC transcriptomics from human blood, can predict a wide range of health-related markers. ClinicalTrial.gov Identifier: NCT01684917. NEW & NOTEWORTHY We developed a novel AI approach based on machine learning to predict general health and foodintake parameters. This approach, named transcriptome-driven health status transversal-predictor analysis, is relevant for markers of diabesity and is based on a mathematics-driven approach. This “one-method” approach enables the simultaneous monitoring of a large number of health-status variables and may facilitate monitoring of therapeutic and preventive strategies. This PBMC transcriptomics-based technique from human blood offers prediction of a wide range of healthrelated markers.

Original languageEnglish
Pages (from-to)58-70
Number of pages13
JournalPhysiological Genomics
Volume58
Issue number1
DOIs
Publication statusPublished - Jan 2026
Externally publishedYes

Keywords

  • diabesity
  • lipidomics
  • metabolomics
  • predictors
  • transcriptomic

Fingerprint

Dive into the research topics of 'Transcriptome-driven health status transversal-predictor analysis for health, food, microbiome, and disease markers for understanding lifestyle diseases'. Together they form a unique fingerprint.

Cite this